Eiger BioPharmaceuticals

Eiger BioPharmaceuticals - Biopharmaceutical company developing a diverse portfolio of well-characterized drugs for orphan diseases.

Industries

Stage

Post IPO Debt

Employees

11-50

Links

Org chart

David Apelian
Interim CEO
Collapse
Christopher Kurtz
Chief Technical Officer
Eldon Mayer, III
EVP, Chief Commercial Officer
Ingrid Choong
SVP, Clinical Development
Colleen Craig
VP, Metabolic Diseases
Ashwini Kadam
Head of Analytical Development and QC
Henk Kocken
Vice President Quality Assurance
Sherri Hubby
Senior Director, GCP QA
Bill Kachioff
Chief Financial Officer
James Vollins
General Counsel, Chief Compliance Officer & Corporate Secretary
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.